Search research articles
Contact Us
Filters
Showing results (91-100 of 105) with videos related to
Page
of 11
Sort By:
Alzheimer'S Research & Therapy
|
January 6, 2020
Clinical significance of focal ß-amyloid deposition measured by <sup>18</sup>F-flutemetamol PET
Si Eun Kim, Byungju Lee, Seongbeom Park, et al.
Journal of Clinical Medicine
|
March 14, 2019
Clinical and Biomarker Characteristics According to Clinical Spectrum of Alzheimer's Disease (AD) in the Validation Cohort of Korean Brain Aging Study for the Early Diagnosis and Prediction of AD
Jihye Hwang, Jee Hyang Jeong, Soo Jin Yoon, et al.
Dementia and Neurocognitive Disorders
|
November 8, 2024
Lecanemab: Appropriate Use Recommendations by Korean Dementia Association
Kee Hyung Park, Geon Ha Kim, Chi-Hun Kim, et al.
Alzheimer'S Research & Therapy
|
February 20, 2021
Cognitive trajectories of patients with focal ß-amyloid deposition
Si Eun Kim, Byungju Lee, Hyemin Jang, et al.
Dementia and Neurocognitive Disorders
|
January 17, 2020
A Comparison Study of Cilostazol and Aspirin on Changes in Volume of Cerebral Small Vessel Disease White Matter Changes: Protocol of a Multicenter, Randomized Controlled Trial
Hyun Jeong Han, Byeong C Kim, Young Chul Youn, et al.
Plos One
|
August 9, 2017
Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial
Kyung Won Park, Eun-Joo Kim, Hyun Jeong Han, et al.
Journal of Alzheimer'S Disease : JAD
|
December 12, 2025
Deep-learning analysis of speech using mel-spectrograms for the assessment of mild cognitive impairment and Alzheimer's disease
Yun Ho Choi, Hyungjun Kim, Suhun Hong, et al.
Stroke
|
November 16, 2021
Cilostazol Versus Aspirin on White Matter Changes in Cerebral Small Vessel Disease: A Randomized Controlled Trial
Byeong C Kim, Young Chul Youn, Jee Hyang Jeong, et al.
BMC Medical Informatics and Decision Making
|
November 23, 2019
Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data
Min Ju Kang, Sang Yun Kim, Duk L Na, et al.
Dementia and Neurocognitive Disorders
|
February 13, 2025
Clinical Practice Guidelines for Dementia: Recommendations for the Pharmacological Treatment of Behavioral and Psychological Symptoms
Gihwan Byeon, Dong Woo Kang, Yeshin Kim, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 105) with videos related to
Sort By:
Page
of 11
Alzheimer'S Research & Therapy
|
January 6, 2020
Clinical significance of focal ß-amyloid deposition measured by <sup>18</sup>F-flutemetamol PET
Si Eun Kim, Byungju Lee, Seongbeom Park, et al.
Journal of Clinical Medicine
|
March 14, 2019
Clinical and Biomarker Characteristics According to Clinical Spectrum of Alzheimer's Disease (AD) in the Validation Cohort of Korean Brain Aging Study for the Early Diagnosis and Prediction of AD
Jihye Hwang, Jee Hyang Jeong, Soo Jin Yoon, et al.
Dementia and Neurocognitive Disorders
|
November 8, 2024
Lecanemab: Appropriate Use Recommendations by Korean Dementia Association
Kee Hyung Park, Geon Ha Kim, Chi-Hun Kim, et al.
Alzheimer'S Research & Therapy
|
February 20, 2021
Cognitive trajectories of patients with focal ß-amyloid deposition
Si Eun Kim, Byungju Lee, Hyemin Jang, et al.
Dementia and Neurocognitive Disorders
|
January 17, 2020
A Comparison Study of Cilostazol and Aspirin on Changes in Volume of Cerebral Small Vessel Disease White Matter Changes: Protocol of a Multicenter, Randomized Controlled Trial
Hyun Jeong Han, Byeong C Kim, Young Chul Youn, et al.
Plos One
|
August 9, 2017
Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer's dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial
Kyung Won Park, Eun-Joo Kim, Hyun Jeong Han, et al.
Journal of Alzheimer'S Disease : JAD
|
December 12, 2025
Deep-learning analysis of speech using mel-spectrograms for the assessment of mild cognitive impairment and Alzheimer's disease
Yun Ho Choi, Hyungjun Kim, Suhun Hong, et al.
Stroke
|
November 16, 2021
Cilostazol Versus Aspirin on White Matter Changes in Cerebral Small Vessel Disease: A Randomized Controlled Trial
Byeong C Kim, Young Chul Youn, Jee Hyang Jeong, et al.
BMC Medical Informatics and Decision Making
|
November 23, 2019
Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data
Min Ju Kang, Sang Yun Kim, Duk L Na, et al.
Dementia and Neurocognitive Disorders
|
February 13, 2025
Clinical Practice Guidelines for Dementia: Recommendations for the Pharmacological Treatment of Behavioral and Psychological Symptoms
Gihwan Byeon, Dong Woo Kang, Yeshin Kim, et al.
Page
of 11